Phase I Trial of Sorafenib Following Liver Transplantation in Patients With High-Risk Hepatocellular Carcinoma.
Journal of Clinical Oncology - United States
doi 10.1200/jco.2015.33.3_suppl.401
Full Text
Open PDFAbstract
Available in full text
Date
January 20, 2015
Authors
Publisher
American Society of Clinical Oncology (ASCO)